93 related articles for article (PubMed ID: 23929905)
1. Financial gain is driving referrals for specialist prostate radiotherapy, says report.
McCarthy M
BMJ; 2013 Aug; 347():f4978. PubMed ID: 23929905
[No Abstract] [Full Text] [Related]
2. The paradox of multidisciplinary care.
Potters L
Int J Radiat Oncol Biol Phys; 2012 Sep; 84(1):20-2. PubMed ID: 22901419
[No Abstract] [Full Text] [Related]
3. The overuse of intensity-modulated radiotherapy and the role of the healthcare payer.
Loblaw DA
Clin Oncol (R Coll Radiol); 2012 Sep; 24(7):459-60. PubMed ID: 22722057
[No Abstract] [Full Text] [Related]
4. Intensity modulated radiation therapy replaces 3-dimensional conformal radiotherapy as prostate cancer treatment.
Elliott SP; Adejoro OO; Konety BR; Jarosek SL; Dusenbery KE; Virnig BA
J Urol; 2012 Apr; 187(4):1253-8. PubMed ID: 22335868
[TBL] [Abstract][Full Text] [Related]
5. Intensity-modulated radiation therapy for prostate cancer.
Jacobs BL; Schroeck FR; Hollenbeck BK
N Engl J Med; 2014 Feb; 370(7):679. PubMed ID: 24521127
[No Abstract] [Full Text] [Related]
6. Intensity-modulated radiation therapy for prostate cancer.
Sartor O; Silberstein JL
N Engl J Med; 2014 Feb; 370(7):679. PubMed ID: 24521126
[No Abstract] [Full Text] [Related]
7. Intensity-modulated radiation therapy for prostate cancer.
Mitchell JM
N Engl J Med; 2014 Feb; 370(7):679-80. PubMed ID: 24521125
[No Abstract] [Full Text] [Related]
8. Re: urologists' use of intensity-modulated radiation therapy for prostate cancer.
Penson DF
J Urol; 2014 May; 191(5):1292. PubMed ID: 24745495
[No Abstract] [Full Text] [Related]
9. Integrated prostate cancer centers and over-utilization of IMRT: a close look at fee-for-service medicine in radiation oncology.
Falit BP; Gross CP; Roberts KB
Int J Radiat Oncol Biol Phys; 2010 Apr; 76(5):1285-8. PubMed ID: 20338470
[No Abstract] [Full Text] [Related]
10. Patterns of practice in intensity-modulated radiation therapy and image-guided radiation therapy for prostate cancer in Japan.
Nakamura K; Akimoto T; Mizowaki T; Hatano K; Kodaira T; Nakamura N; Kozuka T; Shikama N; Kagami Y
Jpn J Clin Oncol; 2012 Jan; 42(1):53-7. PubMed ID: 22131339
[TBL] [Abstract][Full Text] [Related]
11. Certificate of need programs, intensity modulated radiation therapy use and the cost of prostate cancer care.
Khanna A; Hu JC; Gu X; Nguyen PL; Lipsitz S; Palapattu GS
J Urol; 2013 Jan; 189(1):75-9. PubMed ID: 23164382
[TBL] [Abstract][Full Text] [Related]
12. The right therapy for prostate cancer.
Rose CM
Health Aff (Millwood); 2012 Jul; 31(7):1648; author reply 1649. PubMed ID: 22778359
[No Abstract] [Full Text] [Related]
13. Re: Certificate of need regulations and the diffusion of intensity-modulated radiotherapy.
Penson DF
J Urol; 2013 Oct; 190(4):1250-1. PubMed ID: 24029317
[No Abstract] [Full Text] [Related]
14. Use of advanced treatment technologies among men at low risk of dying from prostate cancer.
Sammon JD; Trinh QD; Menon M
BJU Int; 2014 Aug; 114(2):166-7. PubMed ID: 24180347
[No Abstract] [Full Text] [Related]
15. Is intensity-modulated radiotherapy for prostate cancer ready for prime-time?
Rodrigues G
Can J Urol; 2012 Aug; 19(4):6381-2. PubMed ID: 22892262
[No Abstract] [Full Text] [Related]
16. Re: use of advanced treatment technologies among men at low risk of dying from prostate cancer.
See WA
Eur Urol; 2014 Jan; 65(1):250. PubMed ID: 24289855
[No Abstract] [Full Text] [Related]
17. The rationale behind hypofractionated high-dose intensity-modulated radiotherapy in patients with localized prostate cancer: short review.
Szychot E; Brodkiewicz A; Peregud-Pogorzelski J
Ann Acad Med Stetin; 2012; 58(1):45-8. PubMed ID: 23547394
[TBL] [Abstract][Full Text] [Related]
18. Intrafractional prostate motion during online image guided intensity-modulated radiotherapy for prostate cancer.
Budiharto T; Slagmolen P; Haustermans K; Maes F; Junius S; Verstraete J; Oyen R; Hermans J; Van den Heuvel F
Radiother Oncol; 2011 Feb; 98(2):181-6. PubMed ID: 21295871
[TBL] [Abstract][Full Text] [Related]
19. Re: Effect of age, tumor risk, and comorbidity on competing risks for survival in a u.s. Population-based cohort of men with prostate cancer.
Penson DF
J Urol; 2013 Nov; 190(5):1766-7. PubMed ID: 24120782
[No Abstract] [Full Text] [Related]
20. Radiotherapy for prostate cancer.
Rutz HP; Lomax AJ
N Engl J Med; 2007 Jan; 356(3):308-9; author reply 310-1. PubMed ID: 17229963
[No Abstract] [Full Text] [Related]
[Next] [New Search]
